Myanmar vs Uruguay: Cause of death, by non-communicable diseases, ages 15-59
Myanmar
56.4%
in 2021
Uruguay
55.7%
in 2021
Myanmar rank
85th
Uruguay rank
87th
Cause of death, by non-communicable diseases, ages 15-59 over time
- Myanmar
- Uruguay
How they compare
Myanmar currently reports 56.4% against 55.7% in Uruguay, a difference of 0.7%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Uruguay ahead.
Myanmar ranks 85th and Uruguay ranks 87th of 185 countries.
Across the 3 decades both report, Myanmar averaged higher in 1 and Uruguay in 2.
Head to head by decade
| Decade | Myanmar | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 51.2% | 69.2% | 18.0% | Uruguay |
| 2010s | 60.7% | 66.1% | 5.3% | Uruguay |
| 2020s | 61.1% | 60.5% | 0.5% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Myanmar or Uruguay?
- Myanmar, at 56.4% against 55.7% in Uruguay as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Myanmar and Uruguay?
- 0.7%, with Myanmar ahead.
- How many years of comparable data are there for Myanmar and Uruguay?
- 6 years are reported by both, from 2000 to 2021.
- How do Myanmar and Uruguay rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Myanmar ranks 85th and Uruguay ranks 87th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.